XML 82 R27.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Components of Income Tax Expense for Continuing Operations

Components of income tax expense for continuing operations were as follows:

 

 

Year Ended December 31,

 

(in thousands)

2019

 

 

2018

 

 

2017

 

Current:

 

 

 

 

 

 

 

 

 

 

 

Federal

$

 

 

$

(100

)

 

$

 

State

 

9,530

 

 

 

830

 

 

 

 

Total income tax expense

$

9,530

 

 

$

730

 

 

$

 

Provision for Income Taxes on Earnings Subject to Income Taxes Differs from Statutory Federal Rate

The provision for income taxes on earnings subject to income taxes differs from the statutory federal rate due to the following:

 

 

 

December 31,

 

(in thousands)

 

2019

 

 

2018

 

 

2017

 

Federal income taxes at 21% for 2019 and 2018 and 35% for 2017

 

$

9,775

 

 

$

4,587

 

 

$

(49,889

)

State income tax, net of federal benefit

 

 

4,044

 

 

 

361

 

 

 

(4,013

)

Tax effect on non-deductible expenses

 

 

855

 

 

 

446

 

 

 

433

 

Branded prescription drug fee

 

 

3,707

 

 

 

 

 

 

 

Share-based compensation expense

 

 

(12,785

)

 

 

(9,778

)

 

 

(19,589

)

Officer compensation

 

 

3,068

 

 

 

915

 

 

 

2,163

 

Change in tax rate

 

 

(4,143

)

 

 

(198

)

 

 

154,415

 

Expired tax attributes

 

 

1,228

 

 

 

13,874

 

 

 

2,998

 

Research credits

 

 

(10,359

)

 

 

(13,526

)

 

 

(5,596

)

Change in valuation allowance

 

 

13,883

 

 

 

4,306

 

 

 

(79,966

)

Other

 

 

257

 

 

 

(257

)

 

 

(956

)

 

 

$

9,530

 

 

$

730

 

 

$

 

Components of Deferred Tax Assets

 

 

 

December 31,

 

(in thousands)

 

2019

 

 

2018

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating losses

 

$

181,300

 

 

$

223,800

 

Research and development credits

 

 

71,900

 

 

 

62,200

 

Capitalized research and development

 

 

28,000

 

 

 

34,800

 

Share-based compensation expense

 

 

22,900

 

 

 

17,300

 

Operating lease assets

 

 

23,300

 

 

 

100

 

Intangible assets

 

 

49,300

 

 

 

9,400

 

Other

 

 

18,500

 

 

 

19,100

 

Total deferred tax assets

 

 

395,200

 

 

 

366,700

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Convertible senior notes

 

 

(24,100

)

 

 

(26,400

)

Operating lease liabilities

 

 

(18,200

)

 

 

 

Other

 

 

(6,900

)

 

 

(5,100

)

Total deferred tax liabilities

 

 

(49,200

)

 

 

(31,500

)

Net of deferred tax assets and liabilities

 

 

346,000

 

 

 

335,200

 

Valuation allowance

 

 

(346,000

)

 

 

(335,200

)

Net deferred tax assets

 

$

 

 

$

 

 

Activity Related to Unrecognized Tax Benefits

A summary of activity related to unrecognized tax benefits follows:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2019

 

 

2018

 

 

2017

 

Balance at January 1

 

$

54,775

 

 

$

37,403

 

 

$

34,112

 

Increases related to prior year tax positions

 

 

281

 

 

 

6,103

 

 

 

 

Increases related to current year tax positions

 

 

9,519

 

 

 

11,726

 

 

 

3,291

 

Expiration of the statute of limitations for the assessment of taxes

 

 

(657

)

 

 

(457

)

 

 

 

Balance at December 31

 

$

63,918

 

 

$

54,775

 

 

$

37,403